Jamjoom Pharma hits highest price since debut

11/08/2024 Argaam Exclusive

Shares of Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) hit an all-time high today, Aug. 11, at SAR 166.80.

 

The stock closed 1% lower at SAR 159.80 as about 230,000 shares changed hands. 

Market Data :

Open 156.60
Low 153.80
High 157.00
Previous Close 156.60
Change (3M) (6.88 %)
Change (6M) 17.17 %
Market Value 10,794.00
Avg. Volume (3M) 207,178.97
Avg. Turnover (3M) 37,009,836.06
Avg. Transaction (3M) 2,519.32
Change(12M) 36.94 %
YTD 34.09 %

Jamjoom Pharma has not amended its capital since listing on the Saudi Exchange (Tadawul) on June 20, 2023.

Adjustments to the capital (M Riyal) :

Date Type Capital (M Riyal) Change (%)
2023 IPO   700.00 0.00%

Financial Performance :

Overview :

Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) was established as a branch of Abdullatif Mohammed Salah Jamjoom and Brothers Company in 1994 in Jeddah. In 2004, it was converted into a limited liability company and in 2013, it was converted into a closed joint-stock company. The company develops, manufactures and markets a wide range of generic pharmaceutical products through tow strategic products; pharmaceutical products (medicines and drugs) and consumer health products which are sold ...


Financial Ratios :

Financial Ratio Current
Market Cap (M Riyal) 10,794.00
Shares Outstanding ((M)) 70.00
EPS ( Riyal) (TTM) 4.99
Book Value (BV) ( Riyal) (Latest announcement) 20.64
Adjusted P/E (Last12) 30.89
Price/book 7.47
Dividend Yield (%) (Last Year) 1.62
Return on Average Assets (%) (TTM) 19.87
Return on Average Equity (%) (TTM) 24.90
Par Value ( Riyal) 10.00
Enterprise Value (EV) (M) 10,672.18


Analyst Estimates :

156.86

Fair Average Price

1

Number of Recommendations

Rating Research firm Current Price Target Price Change
Buy United Securities Company 136.80 156.86 14.66 %

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.